Active Policy Notifications
Select Cardiology Guidelines
Lab Management Guidelines
News & Announcements
The notifications listed below represent new policy versions that are scheduled to become active on the intended Policy Effective Date. These notifications allow you to become familiar with the new policy version in advance of its release. Please check back frequently as notifications are posted often.
The documents below are strictly notifications of future policy updates. The positions and criteria addressed in the notification are not enforced until the Policy Effective Date. To view current company policies, go to the Policy Bulletins section of this site or click
Policy Effective Date
Notification Issue Date
eviCore Lab Management Program (Independence)
Ground Ambulance Services (Emergency and Nonemergency) (Independence)
Histone Deacetylase Inhibitors for Peripheral T-cell Lymphoma (e.g., Istodax®, Beleodaq®)
Intra-Articular Injection of Hyaluronan for the Treatment of Osteoarthritis
Intravitreal Injection of Vascular Endothelial Growth Factor (VEGF) Antagonists and Related Biosimilars
Physician/Nonphysician Standby Services
Preventive Care Services (Independence)
Talimogene laherparepvec (Imlygic™)
Treatment of Pulmonary Artery Hypertension with Intravenous, Subcutaneous, and Inhaled Pharmacologic Agents
Connect with Us
© 2017 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.